Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyoshi Yokoi

Showing results (41-50 of 223) with videos related to

Pageof 23
Sort By:
Journal of Vascular Surgery|June 28, 2021
Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral arteryTakao Ohki, Kimihiko Kichikawa, Hiroyoshi Yokoi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 29, 2012
Prevalence and clinical outcome of polyvascular atherosclerotic disease in patients undergoing coronary interventionTakashi Miura, Yoshimitsu Soga, Tatsuki Doijiri, et al.
International Heart Journal|June 13, 2012
Clopidogrel trial in patients with elective percutaneous coronary intervention for stable angina and old myocardial infarction (CLEAN)Takaaki Isshiki, Takeshi Kimura, Takafumi Ueno, et al.
Cardiovascular Intervention and Therapeutics|July 27, 2016
Effectiveness of sarpogrelate after endovascular treatment for femoropopliteal artery disease: ESPALIER studyYoshimitsu Soga, Yoshiaki Shintani, Toshimitsu Hamasaki, et al.
Journal of Vascular Surgery|August 31, 2016
Incidence and its characteristics of repetition of reintervention after drug-eluting stent implantation for femoropopliteal lesionOsamu Iida, Mitsuyoshi Takahara, Yoshimitsu Soga, et al.
American Journal of Cardiovascular Disease|January 29, 2015
Impact of the bifurcation angle on major cardiac events after cross-over single stent strategy in unprotected left main bifurcation lesions: 3-dimensional quantitative coronary angiographic analysisKisaki Amemiya, Takenori Domei, Masashi Iwabuchi, et al.
Journal of Vascular Surgery|October 21, 2015
One-year outcomes of the U.S. and Japanese regulatory trial of the Misago stent for treatment of superficial femoral artery disease (OSPREY study)Takao Ohki, John F Angle, Hiroyoshi Yokoi, et al.
Cardiovascular Intervention and Therapeutics|April 8, 2024
Drug intervention as an emerging concept for secondary prevention in patients with coronary diseaseYoshiyasu Minami, Junya Ako, Kenichi Tsujita, et al.
Journal of Vascular Surgery|January 12, 2017
Drug-eluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery diseaseKan Zen, Mitsuyoshi Takahara, Osamu Iida, et al.
Cardiovascular Diabetology|January 10, 2014
High serum C1q-binding adiponectin levels in male patients with acute coronary syndromeKen Kishida, Yasuhiko Nakagawa, Hironori Kobayashi, et al.
Pageof 23

Showing results (41-50 of 223) with videos related to

Sort By:
Pageof 23
Journal of Vascular Surgery|June 28, 2021
Long-term results of the Japanese multicenter Viabahn trial of heparin bonded endovascular stent grafts for long and complex lesions in the superficial femoral arteryTakao Ohki, Kimihiko Kichikawa, Hiroyoshi Yokoi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 29, 2012
Prevalence and clinical outcome of polyvascular atherosclerotic disease in patients undergoing coronary interventionTakashi Miura, Yoshimitsu Soga, Tatsuki Doijiri, et al.
International Heart Journal|June 13, 2012
Clopidogrel trial in patients with elective percutaneous coronary intervention for stable angina and old myocardial infarction (CLEAN)Takaaki Isshiki, Takeshi Kimura, Takafumi Ueno, et al.
Cardiovascular Intervention and Therapeutics|July 27, 2016
Effectiveness of sarpogrelate after endovascular treatment for femoropopliteal artery disease: ESPALIER studyYoshimitsu Soga, Yoshiaki Shintani, Toshimitsu Hamasaki, et al.
Journal of Vascular Surgery|August 31, 2016
Incidence and its characteristics of repetition of reintervention after drug-eluting stent implantation for femoropopliteal lesionOsamu Iida, Mitsuyoshi Takahara, Yoshimitsu Soga, et al.
American Journal of Cardiovascular Disease|January 29, 2015
Impact of the bifurcation angle on major cardiac events after cross-over single stent strategy in unprotected left main bifurcation lesions: 3-dimensional quantitative coronary angiographic analysisKisaki Amemiya, Takenori Domei, Masashi Iwabuchi, et al.
Journal of Vascular Surgery|October 21, 2015
One-year outcomes of the U.S. and Japanese regulatory trial of the Misago stent for treatment of superficial femoral artery disease (OSPREY study)Takao Ohki, John F Angle, Hiroyoshi Yokoi, et al.
Cardiovascular Intervention and Therapeutics|April 8, 2024
Drug intervention as an emerging concept for secondary prevention in patients with coronary diseaseYoshiyasu Minami, Junya Ako, Kenichi Tsujita, et al.
Journal of Vascular Surgery|January 12, 2017
Drug-eluting stenting for femoropopliteal lesions, followed by cilostazol treatment, reduces stent restenosis in patients with symptomatic peripheral artery diseaseKan Zen, Mitsuyoshi Takahara, Osamu Iida, et al.
Cardiovascular Diabetology|January 10, 2014
High serum C1q-binding adiponectin levels in male patients with acute coronary syndromeKen Kishida, Yasuhiko Nakagawa, Hironori Kobayashi, et al.
Pageof 23